Cargando…

Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]

Detalles Bibliográficos
Autores principales: Ruiter, R., Visser, L. E., Stricker, B. H. Ch.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268967/
http://dx.doi.org/10.1007/s00125-011-2448-2
_version_ 1782222428798189568
author Ruiter, R.
Visser, L. E.
Stricker, B. H. Ch.
author_facet Ruiter, R.
Visser, L. E.
Stricker, B. H. Ch.
author_sort Ruiter, R.
collection PubMed
description
format Online
Article
Text
id pubmed-3268967
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-32689672012-02-16 Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter] Ruiter, R. Visser, L. E. Stricker, B. H. Ch. Diabetologia Letter Springer-Verlag 2012-01-12 2012 /pmc/articles/PMC3268967/ http://dx.doi.org/10.1007/s00125-011-2448-2 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letter
Ruiter, R.
Visser, L. E.
Stricker, B. H. Ch.
Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]
title Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]
title_full Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]
title_fullStr Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]
title_full_unstemmed Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]
title_short Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]
title_sort request for clarification from ruiter et al regarding ‘risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. reply to carstensen b [letter]
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268967/
http://dx.doi.org/10.1007/s00125-011-2448-2
work_keys_str_mv AT ruiterr requestforclarificationfromruiteretalregardingriskofcancerinpatientsoninsulinglargineandotherinsulinanaloguesincomparisonwiththoseonhumaninsulinresultsfromalargepopulationbasedfollowupstudyreplytocarstensenbletter
AT visserle requestforclarificationfromruiteretalregardingriskofcancerinpatientsoninsulinglargineandotherinsulinanaloguesincomparisonwiththoseonhumaninsulinresultsfromalargepopulationbasedfollowupstudyreplytocarstensenbletter
AT strickerbhch requestforclarificationfromruiteretalregardingriskofcancerinpatientsoninsulinglargineandotherinsulinanaloguesincomparisonwiththoseonhumaninsulinresultsfromalargepopulationbasedfollowupstudyreplytocarstensenbletter